Loading...
XNYS
COP
Market cap108bUSD
Apr 04, Last price  
85.55USD
1D
-10.18%
1Q
-15.37%
Jan 2017
70.62%
Name

Conocophillips

Chart & Performance

D1W1MN
P/E
11.70
P/S
1.90
EPS
7.31
Div Yield, %
2.74%
Shrs. gr., 5y
1.00%
Rev. gr., 5y
11.83%
Revenues
56.95b
-1.57%
183,364,000,000167,578,000,000194,495,000,000246,182,000,000152,840,000,000198,655,000,000247,149,000,00057,967,000,00054,413,000,00052,524,000,00029,564,000,00023,693,000,00029,106,000,00036,417,000,00032,567,000,00018,784,000,00045,828,000,00078,494,000,00057,861,000,00056,953,000,000
Net income
9.25b
-15.62%
13,617,000,00015,550,000,00011,891,000,000-16,998,000,0004,858,000,00011,358,000,00012,436,000,0008,428,000,0009,156,000,0006,869,000,000-4,428,000,000-3,615,000,000-855,000,0006,257,000,0007,189,000,000-2,655,000,0008,079,000,00018,680,000,00010,957,000,0009,245,000,000
CFO
20.12b
+0.80%
17,628,000,00021,516,000,00024,550,000,00022,658,000,00012,479,000,00017,045,000,00019,646,000,00013,922,000,00016,087,000,00016,735,000,0007,572,000,0004,403,000,0007,077,000,00012,934,000,00011,104,000,0004,802,000,00016,996,000,00028,314,000,00019,965,000,00020,124,000,000
Dividend
Aug 12, 20240.78 USD/sh
Earnings
Apr 30, 2025

Profile

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
URL
https://www.conocophillips.com/
IPO date
Mar 17, 1980
Employees
9,700
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
56,953,000
-1.57%
57,861,000
-26.29%
78,494,000
71.28%
Cost of revenue
20,012,000
29,749,000
48,552,000
Unusual Expense (Income)
NOPBT
36,941,000
28,112,000
29,942,000
NOPBT Margin
64.86%
48.59%
38.15%
Operating Taxes
4,427,000
5,331,000
9,548,000
Tax Rate
11.98%
18.96%
31.89%
NOPAT
32,514,000
22,781,000
20,394,000
Net income
9,245,000
-15.62%
10,957,000
-41.34%
18,680,000
131.22%
Dividends
(3,646,000)
(5,583,000)
(5,726,000)
Dividend yield
3.11%
3.99%
3.80%
Proceeds from repurchase of equity
(5,541,000)
(5,452,000)
(8,908,000)
BB yield
4.73%
3.90%
5.91%
Debt
Debt current
1,035,000
1,267,000
417,000
Long-term debt
24,229,000
19,709,000
17,652,000
Deferred revenue
Other long-term liabilities
11,145,000
9,460,000
9,027,000
Net debt
9,394,000
5,383,000
601,000
Cash flow
Cash from operating activities
20,124,000
19,965,000
28,314,000
CAPEX
(11,248,000)
(10,159,000)
Cash from investing activities
302,000
(12,000,000)
(8,741,000)
Cash from financing activities
(8,835,000)
(8,661,000)
(18,053,000)
FCF
9,098,000
15,803,000
20,439,000
Balance
Cash
6,114,000
6,606,000
9,243,000
Long term investments
9,756,000
8,987,000
8,225,000
Excess cash
13,022,350
12,699,950
13,543,300
Stockholders' equity
23,000
53,616,000
47,050,000
Invested Capital
100,242,000
65,985,050
56,936,700
ROIC
39.12%
37.07%
35.06%
ROCE
33.07%
32.13%
38.29%
EV
Common stock shares outstanding
1,180,871
1,205,675
1,278,163
Price
99.17
-14.56%
116.07
-1.64%
118.00
63.48%
Market cap
117,106,977
-16.32%
139,942,697
-7.21%
150,823,234
57.33%
EV
126,500,977
145,325,697
151,424,234
EBITDA
46,540,000
36,382,000
37,446,000
EV/EBITDA
2.72
3.99
4.04
Interest
783,000
1,063,000
1,055,000
Interest/NOPBT
2.12%
3.78%
3.52%